The Lancet
订阅
1. [Correspondence] New WHO INN for cell-based and gene-based substances: timing, usage, and simplicity Tony Manderson, Ursula Loizides, Massimo Dominici, James S Robertson, Raffaella Balocco
2. [Health Policy] WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines Kristina Jenei, Camille E G Glaus, Kerstin N Vokinger
3. [Correspondence] Nigeria's new policy: solution for the health-care workforce crisis? Gbolahan Olatunji, Nicholas Aderinto, Emmanuel Kokori, Israel Charles Abraham
4. [Editorial] Endometriosis: addressing the roots of slow progress The Lancet
5. [Perspectives] Spreading social capital to improve diversity in medicine Kimberly D Manning, Lauren Jenkins
6. [Perspectives] Honouring our ancestors to advance health justice Michelle Morse
7. [Perspectives] Medicines from the garden Michael Heinrich
8. [Perspectives] Emily Chan: inspiring a mosaic career in public health students Udani Samarasekera
9. [World Report] Jenin's struggle for health care access amid Israeli incursions Clotilde Bigot
10. [World Report] Russia's research drought Ed Holt
11. [Obituary] Sir David Goldberg Geoff Watts
12. [Clinical Picture] Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation Erik L Lum, Nima Nassiri, Neil Kogut, Caspian Oliai, Anne Raldow, Elaine F Reed, Jeffrey L Veale
13. [Correspondence] Time to reboot circumarctic One Health collaboration Christian Sonne, Bjørn M Jenssen, Tomasz M Ciesielski, Katrin Vorkamp, Rune Dietz
14. [Correspondence] Ending plastic pollution from cradle to grave Adam M Finkel
15. [Correspondence] Towards a sustainable future: mitigating the plastic paradox Saravanan Sekaran, Dhanraj Ganapathy
16. [Comment] Offline: Global health's arsenal of laments Richard Horton
17. [Comment] Sepiapterin: a potential new therapy for phenylketonuria Cary O Harding
18. [Seminar] Hypothyroidism Peter N Taylor, Marco M Medici, Alicja Hubalewska-Dydejczyk, Kristien Boelaert
19. [Articles] Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial Ania C Muntau, Nicola Longo, Fatih Ezgu, Ida Vanessa D Schwartz, Melissa Lah, Drago Bratkovic, Lali Margvelashvili, Ertugrul Kiykim, Roberto Zori, Jaume Campistol Plana, Amaya Bélanger-Quintana, Allan Lund, Laura Guilder, Anupam Chakrapani, Halise Neslihan Mungan, Arlindo Guimas, Ixiu del Carmen Cabrales Guerra, Anita MacDonald, Kimberly Ingalls, Neil Smith, APHENITY study group
20. [Correspondence] Reflections on The Lancet menopause Series – Authors' reply Lydia Brown, Myra S Hunter, Carolyn J Crandall, Hadine Joffe Connors, Martha Hickey, Jennifer Doust, Andrea La Croix, Gita D Mishra, Muthusamy Sivakami
21. [Correspondence] Reflections on The Lancet menopause Series Yi Xiao, Minxue Shen, Xiang Chen
22. [Correspondence] Reflections on The Lancet menopause Series Bronwyn G A Stuckey
23. [Correspondence] Reflections on The Lancet menopause Series Gemma Sharp, Alisha Randhawa, Anne Nileshni Fernando
24. [Correspondence] Renaming mpox in Spanish, French, and Portuguese: using language to address stigma and racism Jaime García-Iglesias, Angélica Cabezas-Pino, Francisco Javier Membrillo de Novales, Axel Rodrigo Bautista Pérez, Jorge Garrido Fuentes, Fernando Villaamil Pérez, Alfonso J Rodríguez-Morales, Diego Zamora Estay, Edith Guajardo Zuñiga, Lucas J Núñez Saavedra, Emilio de Benito Cañizares
25. [Correspondence] An urgent case for measles vaccination in Gaza Ronald Waldman, Robert Steinglass, Phillip Nieburg
26. [Comment] Mpox global emergency: strengthening African leadership Ibrahim Abubakar, Julius Lutwama, Catherine Kyobutungi, Osman Sankoh
27. [Comment] Hope emerging in the locally advanced cervical cancer landscape Christine Gennigens
28. [Articles] Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Pier Ramos-Elias, Alejandro Acevedo, Jakub Cvek, Leslie Randall, Andrea Juliana Pereira de Santana Gomes, Fernando Contreras Mejía, Limor Helpman, Hüseyin Akıllı, Jung-Yun Lee, Valeriya Saevets, Flora Zagouri, Lucy Gilbert, Jalid Sehouli, Ekkasit Tharavichitkul, Kristina Lindemann, Nicoletta Colombo, Chih-Long Chang, Marketa Bednarikova, Hong Zhu, Ana Oaknin, Melissa Christiaens, Edgar Petru, Tomoka Usami, Peng Liu, Karin Yamada, Sarper Toker, Stephen M Keefe, Sandro Pignata, Linda R Duska, ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators
29. [Comment] Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma Zachary A Yochum, David A Braun
30. [Articles] Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study Toni K Choueiri, Laurence Albiges, Philippe Barthélémy, Roberto Iacovelli, Sheik Emambux, Javier Molina-Cerrillo, Benjamin Garmezy, Pedro Barata, Arnab Basu, Maria T Bourlon, Helen Moon, Raffaele Ratta, Rana R McKay, Alexander Chehrazi-Raffle, Hans Hammers, Daniel Y C Heng, Edgar Braendle, Kathryn E Beckermann, Bradley A McGregor, Robert J Motzer
更新于 47 分钟前

近期历史最近 100 条记录

2024-10-04 [Correspondence] New WHO INN for cell-based and gene-based substances: timing, usage, and simplicity Tony Manderson, Ursula Loizides, Massimo Dominici, James S Robertson, Raffaella Balocco
2024-10-04 [Health Policy] WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines Kristina Jenei, Camille E G Glaus, Kerstin N Vokinger
2024-10-04 [Correspondence] Nigeria's new policy: solution for the health-care workforce crisis? Gbolahan Olatunji, Nicholas Aderinto, Emmanuel Kokori, Israel Charles Abraham
2024-10-04 [Editorial] Endometriosis: addressing the roots of slow progress The Lancet
2024-10-04 [Perspectives] Spreading social capital to improve diversity in medicine Kimberly D Manning, Lauren Jenkins
2024-10-04 [Perspectives] Honouring our ancestors to advance health justice Michelle Morse
2024-10-04 [Perspectives] Medicines from the garden Michael Heinrich
2024-10-04 [Perspectives] Emily Chan: inspiring a mosaic career in public health students Udani Samarasekera
2024-10-04 [World Report] Jenin's struggle for health care access amid Israeli incursions Clotilde Bigot
2024-10-04 [World Report] Russia's research drought Ed Holt
2024-10-04 [Obituary] Sir David Goldberg Geoff Watts
2024-10-04 [Clinical Picture] Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation Erik L Lum, Nima Nassiri, Neil Kogut, Caspian Oliai, Anne Raldow, Elaine F Reed, Jeffrey L Veale
2024-10-04 [Correspondence] Time to reboot circumarctic One Health collaboration Christian Sonne, Bjørn M Jenssen, Tomasz M Ciesielski, Katrin Vorkamp, Rune Dietz
2024-10-04 [Correspondence] Ending plastic pollution from cradle to grave Adam M Finkel
2024-10-04 [Correspondence] Towards a sustainable future: mitigating the plastic paradox Saravanan Sekaran, Dhanraj Ganapathy
2024-10-04 [Comment] Offline: Global health's arsenal of laments Richard Horton
2024-10-04 [Comment] Sepiapterin: a potential new therapy for phenylketonuria Cary O Harding
2024-10-04 [Seminar] Hypothyroidism Peter N Taylor, Marco M Medici, Alicja Hubalewska-Dydejczyk, Kristien Boelaert
2024-10-04 [Articles] Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial Ania C Muntau, Nicola Longo, Fatih Ezgu, Ida Vanessa D Schwartz, Melissa Lah, Drago Bratkovic, Lali Margvelashvili, Ertugrul Kiykim, Roberto Zori, Jaume Campistol Plana, Amaya Bélanger-Quintana, Allan Lund, Laura Guilder, Anupam Chakrapani, Halise Nesliha
2024-10-04 [Correspondence] Reflections on The Lancet menopause Series – Authors' reply Lydia Brown, Myra S Hunter, Carolyn J Crandall, Hadine Joffe Connors, Martha Hickey, Jennifer Doust, Andrea La Croix, Gita D Mishra, Muthusamy Sivakami
2024-10-04 [Correspondence] Reflections on The Lancet menopause Series Yi Xiao, Minxue Shen, Xiang Chen
2024-10-04 [Correspondence] Reflections on The Lancet menopause Series Bronwyn G A Stuckey
2024-10-04 [Correspondence] Reflections on The Lancet menopause Series Gemma Sharp, Alisha Randhawa, Anne Nileshni Fernando
2024-10-04 [Correspondence] Renaming mpox in Spanish, French, and Portuguese: using language to address stigma and racism Jaime García-Iglesias, Angélica Cabezas-Pino, Francisco Javier Membrillo de Novales, Axel Rodrigo Bautista Pérez, Jorge Garrido Fuentes, Fernando Villaamil Pérez, Alfonso J Rodríguez-Morales, Diego Zamora Estay, Edith Guajardo Zuñiga, Lucas J Núñez Saaved
2024-10-04 [Comment] Mpox global emergency: strengthening African leadership Ibrahim Abubakar, Julius Lutwama, Catherine Kyobutungi, Osman Sankoh
2024-10-04 [Correspondence] An urgent case for measles vaccination in Gaza Ronald Waldman, Robert Steinglass, Phillip Nieburg
2024-10-04 [Articles] Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, p Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Pier Ramos-Elias, Alejandro Acevedo, Jakub Cvek, Leslie Randall, Andrea Juliana Pereira de Santana Gomes, Fernando Contreras Mejía, Limor Helpman, Hüseyin Akıllı, Jung-Yun Lee,
2024-10-04 [Comment] Hope emerging in the locally advanced cervical cancer landscape Christine Gennigens
2024-10-04 [Articles] Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study Toni K Choueiri, Laurence Albiges, Philippe Barthélémy, Roberto Iacovelli, Sheik Emambux, Javier Molina-Cerrillo, Benjamin Garmezy, Pedro Barata, Arnab Basu, Maria T Bourlon, Helen Moon, Raffaele Ratta, Rana R McKay, Alexander Chehrazi-Raffle, Hans Hammer
2024-10-04 [Comment] Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma Zachary A Yochum, David A Braun
2024-09-27 [Review] Endovascular management of acute stroke Thanh N Nguyen, Mohamad Abdalkader, Urs Fischer, Zhongming Qiu, Simon Nagel, Hui-Sheng Chen, Zhongrong Miao, Pooja Khatri
2024-09-27 [Editorial] Organ donation: lessons from the Spanish model The Lancet
2024-09-27 [Perspectives] Jens Juul Holst: physician-scientist and co-discoverer of GLP-1 Geoff Watts
2024-09-27 [Perspectives] Fixing systems not fathers Sarah Hawkes
2024-09-27 [World Report] Vaccination under way as mpox cases continue to rise Paul Adepoju
2024-09-27 [World Report] Populations “woefully unprepared” for climate crisis John Zarocostas
2024-09-27 [World Report] “The final warning sign”: XDR typhoid Misbah Khan
2024-09-27 [Comment] Offline: Xenotransplantation—a new era beckons Richard Horton
2024-09-27 [Clinical Picture] Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia Curtis Marcoux, Pinkesh Thakkar, David M Conrad, Allam A Shawwa, Luke Y C Chen
2024-09-27 [Perspectives] Physician heal thyself Daniel Marchalik, Diane Rehm
2024-09-27 [Obituary] Mildred Stahlman Andrew Green
2024-09-27 [Correspondence] The Lancet Countdown on health and climate change: competing interests and optimism bias – Authors' reply Marina Romanello, Anthony Costello
2024-09-27 [Correspondence] The Lancet Countdown on health and climate change: competing interests and optimism bias Colin D Butler, Devin Combs Bowles, Ivan C Hanigan, Andrew Harmer, John Donne Potter
2024-09-27 [Correspondence] Antibody titres after vaccination: a missing key to rabies control Sarita Phuyal, Krishna Prasad Acharya, Dong Keon Yon
2024-09-27 [Correspondence] The Lancet Countdown on health and climate change: representation matters – Authors' reply Marina Romanello, Paul J Beggs, Wenjia Cai, Georgiana Gordon-Strachan, Stella Hartinger, Kris Murray, Cathryn Tonne
2024-09-27 [Correspondence] The Lancet Countdown on health and climate change: competing interests and optimism bias Nicholas Brink, Matthew F Chersich
2024-09-27 [Department of Error] Department of Error
2024-09-27 [Correspondence] The Lancet Countdown on health and climate change: representation matters Renée Street, Caradee Y Wright
2024-09-27 [Department of Error] Department of Error
2024-09-27 [Correspondence] Operationalising the One Health approach for rabies elimination Sheikh Mohd Saleem, Shah Sumaya Jan
2024-09-27 [Articles] Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 GBD 2021 Antimicrobial Resistance Collaborators
2024-09-27 [Comment] Global burden of antimicrobial resistance and forecasts to 2050 Samuel Kariuki
2024-09-27 [Department of Error] Department of Error
2024-09-27 [Articles] 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial Michael J Morris, Daniel Castellano, Ken Herrmann, Johann S de Bono, Neal D Shore, Kim N Chi, Michael Crosby, Josep M Piulats, Aude Fléchon, Xiao X Wei, Hakim Mahammedi, Guilhem Roubaud, Hana Študentová, James Nagarajah, Begoña Mellado, Álvaro Montesa-Pin
2024-09-27 [Comment] 177Lu-PSMA-617 for metastatic prostate cancer: aiming for the right spot Joaquin Mateo, Amado J Zurita
2024-09-27 [Articles] Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, p Jonathan D Spicer, Marina C Garassino, Heather Wakelee, Moishe Liberman, Terufumi Kato, Masahiro Tsuboi, Se-Hoon Lee, Ke-Neng Chen, Christophe Dooms, Margarita Majem, Ekkehard Eigendorff, Gastón L Martinengo, Olivier Bylicki, Delvys Rodríguez-Abreu, Jamie
2024-09-27 [Comment] Improved survival for patients with lung cancer treated with perioperative immunotherapy Carolyn J Presley, Dwight H Owen
2024-09-27 [Correspondence] Mpox and breastmilk: for once, can we act in time? Prince Imani-Musimwa, Mija Ververs
2024-09-27 [Correspondence] Childhood health and nutrition challenges in Sudan's conflict zones Ibrahim Nagmeldin Hassan, Nagmeldin Abuassa, Mohamed Ibrahim
2024-09-27 [Review] Lipoprotein(a) and cardiovascular disease Børge G Nordestgaard, Anne Langsted
2024-09-27 [Comment] Long-term ill health in sepsis survivors: an ignored health-care challenge? Abi Beane, Manu Shankar-Hari
2024-09-27 [Correspondence] The need for point-of-care tests for mpox Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna, Jean-Vivien Mombouli
2024-09-20 [Correspondence] Safe and equitable use of clinical decision support systems Thomas J Hwang, Quoc-Dien Trinh, Elisaveta Sokolov
2024-09-20 [Editorial] Divisions over lecanemab: keeping an open mind The Lancet
2024-09-20 [Articles] Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial René Adam, Céline Piedvache, Laurence Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean-Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwi
2024-09-20 [Correspondence] Building safe health-care environments in China: urgent challenges Xinyue Yang, Zhiyi Zhang, Zhiqiang Zhang
2024-09-20 [Perspectives] Abolitionist child protection Jocelyn Brown, Sayantani DasGupta
2024-09-20 [Perspectives] Stella Kyriakides: using her voice to improve health in Europe Jessamy Bagenal
2024-09-20 [Perspectives] Abusive medical research, whistleblowers, and institutional power Jeremy Greene
2024-09-20 [World Report] The 2024 Lasker Awards Talha Burki
2024-09-20 [World Report] 10 years of civil war in Yemen Sharmila Devi
2024-09-20 [Comment] Offline: From Wanless to Darzi—don’t miss this opportunity (again) Richard Horton
2024-09-20 [Obituary] John Robin Warren Geoff Watts
2024-09-20 [Correspondence] The humanitarian system: politics can not be avoided Shatha Elnakib, Sarah Aly, Yara M Asi, Yusra Ribhi Shawar
2024-09-20 [Correspondence] Time for a global human rights treaty for health equity Eric A Friedman, Ruth M Mabry, Richard Obedi, Arachu Castro, Alexandra Finch, John Wangai, Luiz A C Galvao, Eze Eluchie, Gonzalo Hünicken, Miguel Correia, Seth Nimwesiga, Adi Radhakrishnan, Lawrence O Gostin
2024-09-20 [Correspondence] Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement Khalid El Bairi, Dario Trapani
2024-09-20 [Correspondence] Health-care workers in fragile and conflict-ridden contexts Patricia St Louis, Samuel Lwamushi Makali, Elisabeth Paul
2024-09-20 [Correspondence] Cuban doctors cannot be the definitive solution for Italy Stefano Rausei, Andrea Giuseppe Bertolini
2024-09-20 [Correspondence] Cuban doctors in Calabria and the Italian health system crisis Mirko Barone, Giuseppe Massimiliano De Luca, Felice Mucilli, Mario Testini
2024-09-20 [Correspondence] Chinese medical legislation: punishment with little protection? Rui Zhao, Zhe-an Shen, Yingze Hou
2024-09-20 [Comment] The promise of once-weekly insulins for type 1 diabetes: update on progress Kaitlin M Love, Sue A Brown
2024-09-20 [Comment] Liver transplantation in metastatic colorectal cancer: a new standard of care? Volker Heinemann, Sebastian Stintzing
2024-09-20 [Clinical Picture] Progressive cervical osteophytosis and dysphagia associated with isotretinoin treatment for rosacea Kamran Naraghi, Helena Marzo-Ortega
2024-09-20 [Department of Error] Department of Error
2024-09-20 [Articles] Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial Richard M Bergenstal, Ruth S Weinstock, Chantal Mathieu, Yukiko Onishi, Vishali Vijayanagaram, Michelle L Katz, Molly C Carr, Annette M Chang
2024-09-20 [Correspondence] A call for global solidarity and rapid action to control mpox Jean B Nachega, Jean‑Jacques Muyembe‑Tamfum, Francine Ntoumi, Placide Mbala‑Kingebeni, Alimuddin Zumla
2024-09-20 [Comment] Antimicrobial resistance at a crossroads: the cost of inaction Michael Craig, Daniel Jernigan, Kayla Laserson, Stefanie McBride, Jessica Fairbanks, Dawn Sievert, Paige A Armstrong, Heather Ewing Ogle, Howard Zucker
2024-09-20 [Series] Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children Clint Pecenka, Erin Sparrow, Daniel R Feikin, Padmini Srikantiah, Delese Mimi Darko, Eric Karikari-Boateng, Ranju Baral, Carla Vizzotti, Analia Rearte, Rose Jalang'o, Jessica A Fleming, Federico Martinón-Torres, Ruth A Karron
2024-09-20 [Series] Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies Natalie I Mazur, Mauricio T Caballero, Marta C Nunes
2024-09-20 [Articles] Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Pardeep S Jhund, Atefeh Talebi, Alasdair D Henderson, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Scott D Solomon, John J V McMurray
2024-09-20 [Comment] Mineralocorticoid receptor antagonists for every patient with heart failure Frans H Rutten, Amy Groenewegen
2024-09-20 [Comment] The role of caregivers in mental health and child development policy and practice Tracey Smythe, Julian Eaton, Adanech Abiebie, Andrea Hernandez Arriaga, Emily Miner
2024-09-13 [Review] Bayesian statistics for clinical research Ewan C Goligher, Anna Heath, Michael O Harhay
2024-09-13 [Editorial] Direct-to-consumer medical testing: an industry built on fear The Lancet
2024-09-13 [Perspectives] Unveiling the exploitation of women's health Shirin Heidari
2024-09-13 [Correspondence] Antimicrobial use at end of life: a missing link in public health discourse Shila Pandey, Renee Wisniewski, Tiffanny Newman, Susan K Seo, William E Rosa
2024-09-13 [Correspondence] Antimicrobial resistance in paediatric blast and crush injuries Emily Mayhew, Anthony Bull, Sumudith Jayasuriya
2024-09-13 [Correspondence] Demanding attention to self-medication with antibiotics Umadevi Subramanian, Baskar Venkidasamy
2024-09-13 [Correspondence] A call for antibiotic stewardship initiatives for dentistry in India Deepavalli Arumuganainar
2024-09-13 [Department of Error] Department of Error

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选